A citation-based method for searching scientific literature

Serge Masson, Roberto Latini, Inder S Anand, Simona Barlera, Laura Angelici, Tarcisio Vago, Gianni Tognoni, Jay N Cohn. J Am Coll Cardiol 2008
Times Cited: 250







List of co-cited articles
551 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
28

Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
25

Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
G Michael Felker, Kevin J Anstrom, Kirkwood F Adams, Justin A Ezekowitz, Mona Fiuzat, Nancy Houston-Miller, James L Januzzi, Daniel B Mark, Ileana L Piña, Gayle Passmore,[...]. JAMA 2017
277
21

Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
Michael R Zile, Brian L Claggett, Margaret F Prescott, John J V McMurray, Milton Packer, Jean L Rouleau, Karl Swedberg, Akshay S Desai, Jianjian Gong, Victor C Shi,[...]. J Am Coll Cardiol 2016
194
20

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
Gregg C Fonarow, William F Peacock, Christopher O Phillips, Michael M Givertz, Margarita Lopatin. J Am Coll Cardiol 2007
359
15

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur J Heart Fail 2016
14

Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.
James L Januzzi, Shafiq U Rehman, Asim A Mohammed, Anju Bhardwaj, Linda Barajas, Justine Barajas, Han-Na Kim, Aaron L Baggish, Rory B Weiner, Annabel Chen-Tournoux,[...]. J Am Coll Cardiol 2011
258
14

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).
Inder S Anand, Lloyd D Fisher, Yann-Tong Chiang, Roberto Latini, Serge Masson, Aldo P Maggioni, Robert D Glazer, Gianni Tognoni, Jay N Cohn. Circulation 2003
643
13

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.
Paulo Bettencourt, Ana Azevedo, Joana Pimenta, Fernando Friões, Susana Ferreira, António Ferreira. Circulation 2004
534
13

NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.
James L Januzzi, Roland van Kimmenade, John Lainchbury, Antoni Bayes-Genis, Jordi Ordonez-Llanos, Miguel Santalo-Bel, Yigal M Pinto, Mark Richards. Eur Heart J 2006
733
13

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
Alan S Maisel, Padma Krishnaswamy, Richard M Nowak, James McCord, Judd E Hollander, Philippe Duc, Torbjørn Omland, Alan B Storrow, William T Abraham, Alan H B Wu,[...]. N Engl J Med 2002
13

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Monica M Colvin, Mark H Drazner, Gerasimos S Filippatos, Gregg C Fonarow, Michael M Givertz,[...]. Circulation 2017
13

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Mark H Drazner, Gregg C Fonarow, Stephen A Geraci, Tamara Horwich, James L Januzzi,[...]. J Am Coll Cardiol 2013
12

The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
James L Januzzi, Carlos A Camargo, Saif Anwaruddin, Aaron L Baggish, Annabel A Chen, Daniel G Krauser, Roderick Tung, Renee Cameron, J Tobias Nagurney, Claudia U Chae,[...]. Am J Cardiol 2005
830
12

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis.
Richard W Troughton, Christopher M Frampton, Hans-Peter Brunner-La Rocca, Matthias Pfisterer, Luc W M Eurlings, Hans Erntell, Hans Persson, Christopher M O'Connor, Deddo Moertl, Patric Karlström,[...]. Eur Heart J 2014
183
12

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Mark H Drazner, Gregg C Fonarow, Stephen A Geraci, Tamara Horwich, James L Januzzi,[...]. Circulation 2013
11

Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
Inder S Anand, Tibor Kempf, Thomas S Rector, Heike Tapken, Tim Allhoff, Franziska Jantzen, Michael Kuskowski, Jay N Cohn, Helmut Drexler, Kai C Wollert. Circulation 2010
211
10

Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
James L Januzzi, Rahul Sakhuja, Michelle O'donoghue, Aaron L Baggish, Saif Anwaruddin, Claudia U Chae, Renee Cameron, Daniel G Krauser, Roderick Tung, Carlos A Camargo,[...]. Arch Intern Med 2006
186
10

Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.
Gianluigi Savarese, Francesca Musella, Carmen D'Amore, Enrico Vassallo, Teresa Losco, Francesco Gambardella, Milena Cecere, Laura Petraglia, Gennaro Pagano, Luigi Fimiani,[...]. JACC Heart Fail 2014
74
12

Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.
Franz Hartmann, Milton Packer, Andrew J S Coats, Michael B Fowler, Henry Krum, Paul Mohacsi, Jean L Rouleau, Michal Tendera, Alain Castaigne, Stefan D Anker,[...]. Circulation 2004
245
9

The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial.
Serge Masson, Roberto Latini, Emanuele Carbonieri, Luciano Moretti, Maria Grazia Rossi, Santo Ciricugno, Valentina Milani, Roberto Marchioli, Joachim Struck, Andreas Bergmann,[...]. Eur J Heart Fail 2010
116
9

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
Matthias Pfisterer, Peter Buser, Hans Rickli, Marc Gutmann, Paul Erne, Peter Rickenbacher, André Vuillomenet, Urs Jeker, Paul Dubach, Hansjürg Beer,[...]. JAMA 2009
442
9

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Milton Packer, John J V McMurray, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. Circulation 2015
447
9

Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.
Mark Ledwidge, Joseph Gallagher, Carmel Conlon, Elaine Tallon, Eoin O'Connell, Ian Dawkins, Chris Watson, Rory O'Hanlon, Margaret Bermingham, Anil Patle,[...]. JAMA 2013
341
9

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.
John J V McMurray, Stamatis Adamopoulos, Stefan D Anker, Angelo Auricchio, Michael Böhm, Kenneth Dickstein, Volkmar Falk, Gerasimos Filippatos, Cândida Fonseca, Miguel Angel Gomez-Sanchez,[...]. Eur Heart J 2012
8

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
Scott D Solomon, Michael Zile, Burkert Pieske, Adriaan Voors, Amil Shah, Elisabeth Kraigher-Krainer, Victor Shi, Toni Bransford, Madoka Takeuchi, Jianjian Gong,[...]. Lancet 2012
787
8

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.
John G Lainchbury, Richard W Troughton, Kim M Strangman, Christopher M Frampton, Anna Pilbrow, Timothy G Yandle, Amjad K Hamid, M Gary Nicholls, A Mark Richards. J Am Coll Cardiol 2009
261
8

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
Serge Masson, Roberto Latini, Inder S Anand, Tarcisio Vago, Laura Angelici, Simona Barlera, Emil D Missov, Aldo Clerico, Gianni Tognoni, Jay N Cohn. Clin Chem 2006
269
8

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
G Michael Felker, Vic Hasselblad, Adrian F Hernandez, Christopher M O'Connor. Am Heart J 2009
242
8

Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
Sheryl L Chow, Alan S Maisel, Inder Anand, Biykem Bozkurt, Rudolf A de Boer, G Michael Felker, Gregg C Fonarow, Barry Greenberg, James L Januzzi, Michael S Kiernan,[...]. Circulation 2017
314
8

Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.
Christopher R deFilippi, Robert H Christenson, John S Gottdiener, Willem J Kop, Stephen L Seliger. J Am Coll Cardiol 2010
91
7

Spironolactone for heart failure with preserved ejection fraction.
Bertram Pitt, Marc A Pfeffer, Susan F Assmann, Robin Boineau, Inder S Anand, Brian Claggett, Nadine Clausell, Akshay S Desai, Rafael Diaz, Jerome L Fleg,[...]. N Engl J Med 2014
7

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
John G F Cleland, John J V McMurray, John Kjekshus, Jan H Cornel, Peter Dunselman, Cândida Fonseca, Ake Hjalmarson, Jerzy Korewicki, Magnus Lindberg, Naresh Ranjith,[...]. J Am Coll Cardiol 2009
171
7

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.
Patrick Jourdain, Guillaume Jondeau, François Funck, Pascal Gueffet, Alain Le Helloco, Erwan Donal, Jean F Aupetit, Marie C Aumont, Michel Galinier, Jean C Eicher,[...]. J Am Coll Cardiol 2007
487
7

Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure.
Hanna K Gaggin, Jackie Szymonifka, Anju Bhardwaj, Arianna Belcher, Benedetta De Berardinis, Shweta Motiwala, Thomas J Wang, James L Januzzi. JACC Heart Fail 2014
156
7


Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study.
Luc W M Eurlings, Petra E J van Pol, Wouter E Kok, Sandra van Wijk, Cara Lodewijks-van der Bolt, Aggie H M M Balk, Dirk J A Lok, Harry J G M Crijns, Dave J W van Kraaij, Nicolaas de Jonge,[...]. J Am Coll Cardiol 2010
146
7


The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failure.
Monica R Shah, Robert M Califf, Anju Nohria, Manju Bhapkar, Margaret Bowers, Donna M Mancini, Mona Fiuzat, Lynne W Stevenson, Christopher M O'Connor. J Card Fail 2011
98
6

Soluble concentrations of the interleukin receptor family member ST2 and β-blocker therapy in chronic heart failure.
Hanna K Gaggin, Shweta Motiwala, Anju Bhardwaj, Kimberly A Parks, James L Januzzi. Circ Heart Fail 2013
98
6

Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
Tibor Kempf, Stephan von Haehling, Timo Peter, Tim Allhoff, Mariantonietta Cicoira, Wolfram Doehner, Piotr Ponikowski, Gerasimos S Filippatos, Piotr Rozentryt, Helmut Drexler,[...]. J Am Coll Cardiol 2007
329
6

Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.
Pardeep S Jhund, Inder S Anand, Michel Komajda, Brian L Claggett, Robert S McKelvie, Michael R Zile, Peter E Carson, John J V McMurray. Eur J Heart Fail 2015
47
12

Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
Inder S Anand, Thomas S Rector, John G Cleland, Michael Kuskowski, Robert S McKelvie, Hans Persson, John J McMurray, Michael R Zile, Michel Komajda, Barry M Massie,[...]. Circ Heart Fail 2011
187
6

Natriuretic peptides.
Lori B Daniels, Alan S Maisel. J Am Coll Cardiol 2007
751
6

Incremental prognostic value of changes in B-type natriuretic peptide in heart failure.
Roberto Latini, Serge Masson, Maylene Wong, Simona Barlera, Elisa Carretta, Lidia Staszewsky, Tarciso Vago, Aldo P Maggioni, Inder S Anand, Lip B Tan,[...]. Am J Med 2006
90
6

Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study.
James L Januzzi, W Frank Peacock, Alan S Maisel, Claudia U Chae, Robert L Jesse, Aaron L Baggish, Michelle O'Donoghue, Rahul Sakhuja, Annabel A Chen, Roland R J van Kimmenade,[...]. J Am Coll Cardiol 2007
370
6

Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea.
Ravi V Shah, Quynh A Truong, Hanna K Gaggin, Jens Pfannkuche, Oliver Hartmann, James L Januzzi. Eur Heart J 2012
97
6


Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.
R W Troughton, C M Frampton, T G Yandle, E A Espiner, M G Nicholls, A M Richards. Lancet 2000
6

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.
Roland R van Kimmenade, James L Januzzi, Patrick T Ellinor, Umesh C Sharma, Jaap A Bakker, Adrian F Low, Abelardo Martinez, Harry J Crijns, Calum A MacRae, Paul P Menheere,[...]. J Am Coll Cardiol 2006
421
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.